These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 21081801

  • 1. The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis.
    Cichoz-Lach H, Celinski K, Konturek PC, Konturek SJ, Slomka M.
    J Physiol Pharmacol; 2010 Oct; 61(5):577-80. PubMed ID: 21081801
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
    Gonciarz M, Gonciarz Z, Bielanski W, Mularczyk A, Konturek PC, Brzozowski T, Konturek SJ.
    J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis.
    Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O.
    Scand J Gastroenterol; 2007 Sep; 42(9):1095-101. PubMed ID: 17710676
    [Abstract] [Full Text] [Related]

  • 8. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 9. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.
    Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ.
    Hepatology; 2003 Aug; 38(2):413-9. PubMed ID: 12883485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, Orszulak-Michalak D, Sporny S, Malecka-Panas E.
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [Abstract] [Full Text] [Related]

  • 13. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.
    Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, Austin AS, Freeman JG, Morgan L, Webber J.
    Gastroenterology; 2008 Oct; 135(4):1176-84. PubMed ID: 18718471
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB, Alves VA, Carrilho FJ.
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.